2022.02.09_S.O. 553(E)_ Stockpiling of new drug under phase 3 of clinical trial_NDCTR,2019_ Amendment 4
NDCTR_G.S.R. 14(E) dt_13.01.2022_To amend rule 2 to substitute cell or stem cell derived product under NDCTR 2019_ Amendment 2
NDCTR_G.S.R. 21(E) dt_18.01.2022_Amendment in Eighth Schedule, Form CT-03_ Amendment 3
NDCTR_G.S.R. 364(E) dt_11.05.2023_Notification for registration of Clinical Research Organisation (CRO)_Amendment 2023 2
NDCTR_G.S.R. 175(E) dt_09.03.2023_Use of induced Pluripotent Stem Cells additional testing methods_ Amendment 2023 1
NDCTR_G.S.R. 605(E) dt_31.08.2021_Standalone Bioanalytical laboratory_Rule2 NDCTR 2019_ Amendment 1
NDCTR_G.S.R. 227(E) dt_19.03.2019_New Drugs & Clinical Trial Rules, 2019
